The lung immune prognostic index as a predictive biomarker in urological malignancies undergoing immune checkpoint inhibitor therapy
The LIPI emerges as a valuable prognostic biomarker in patients with urological malignancies treated with ICIs therapy.
Authors
- Pengcheng Luo (ORCID: https://orcid.org/0000-0003-2230-2854)
- Yan He (ORCID: https://orcid.org/0000-0002-0949-8525)
- Yuan Yuan (ORCID: https://orcid.org/0000-0002-4439-6057)
- Lili Li (ORCID: https://orcid.org/0000-0002-0292-5889)
- Xiao Wei (ORCID: https://orcid.org/0000-0002-2916-4821)
Institutions
- Wuhan University (CN)
- Tongren Hospital (CN)
- Panyu District Central Hospital (CN)
- Wuhan Third Hospital (CN)
- Renmin Hospital of Wuhan University (CN)
- Wuhan University of Science and Technology (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1080/07853890.2025.2582907
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00